- Home
- SNN
as of 12-15-2025 3:35pm EST
$32.20
$0.41
-1.26%
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Chart Type:
Time Range:
| Founded: | 1856 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 14.0B | IPO Year: | 1999 |
| Target Price: | $32.83 | AVG Volume (30 days): | 497.0K |
| Analyst Decision: | Hold | Number of Analysts: | 4 |
| Dividend Yield: | Dividend Payout Frequency: | Semi-Annual | |
| EPS: | 0.56 | EPS Growth: | 59.91 |
| 52 Week Low/High: | $23.69 - $38.79 | Next Earning Date: | 03-02-2026 |
| Revenue: | $5,944,000,000 | Revenue Growth: | 5.35% |
| Revenue Growth (this year): | 7.78% | Revenue Growth (next year): | 5.13% |
AI-Powered SNN Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.00%
75.00%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Smith & Nephew SNATS Inc. News
SNN Breaking Stock News: Dive into SNN Ticker-Specific Updates for Smart Investing
MT Newswires
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
📊
AI Sentiment
Positive
7/10
Compare SNN vs Leading Stocks
See how SNN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SNN Smith & Nephew SNATS Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.